思力华能倍乐中国上市了吗
It is used to treat dyspnea caused by airway obstructive diseases such as bronchial asthma, chronic bronchitis, wheezing bronchitis, and emphysema. Spirava Respimat is especially suitable for patients who need to take long-term adrenergic β2 receptor agonists and patients with nocturnal asthma.
Is Sliva Respimat available on the market in China? It is understood that Sliva Respimat has been launched in the country.
The recommended dose of Respimat Tiotropium Bromide Spray is: Respimat is effective 24 hours a day, so it only needs to be used once a day, and if possible, at the same time every day. Spray twice with each use.
Patients should note: Because adult chronic obstructive pulmonary disease (COPD) is a long-term condition, use Respimat every day, not just when you have breathing problems. Do not exceed recommended dosage. Slivar Respimat is a once-daily maintenance bronchodilator and cannot be used as a rescue treatment for acute episodes of bronchospasm.
Using Spirava Respimat will also cause certain side effects or adverse reactions, among which the common adverse reactions are: dry mouth. Uncommon adverse reactions: dizziness/difficulty sleeping/headache/high blood pressure/irregular heartbeat//palpitations/rapid heartbeat/cough/constipation, etc. Rare adverse reactions: nasopharyngitis/sore throat (pharyngitis)/laryngitis/joint pain/back pain/difficulty urinating (urinary retention)/severe allergic reaction/causing swelling of the mouth, face or throat (angioedema)/itching/urticaria, etc. Before receiving treatment with Seriva Respimat, patients should go to the hospital for a detailed examination and strictly follow the doctor's diagnosis and treatment recommendations. During the treatment period, patients should not increase or decrease the dosage of drugs without authorization. Only correct use of drugs will help the condition.
The above is the introduction about it, I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.
Recommended related hot articles: /newsDetail/82255.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)